Laboratory of Enzymology and Recombinant DNA Technology, Department of Microbiology, Maharshi Dayanand University, Rohtak, Haryana, 124001, India.
Department of Microbiology, Faculty of Allied Health Sciences, SGT University, Gurgaon-Badli Road Chandu, Budhera, Gurugram, Haryana, 122505, India.
Biotechnol Lett. 2024 Oct;46(5):807-826. doi: 10.1007/s10529-024-03510-2. Epub 2024 Jul 10.
Diclofenac is a hepatotoxic non-steroidal anti-inflammatory drug (NSAID) that affects liver histology and its protein expression levels. Here, we studied the effect of diclofenac on rat liver when co-administrated with either Yersinia enterocolitica strain 8081 serotype O:8 biovar 1B (DY) or Lactobacillus fermentum strain 9338 (DL). Spectroscopic analysis of stool samples showed biotransformation of diclofenac. When compared with each other, DY rats lack peaks at 1709 and 1198 cm, while DL rats lack peaks at 1411 cm. However, when compared to control, both groups lack peaks at 1379 and 1170 cm. Assessment of serum biomarkers of hepatotoxicity indicated significantly altered activities of AST (DY: 185.65 ± 8.575 vs Control: 61.9 ± 2.607, DL: 247.5 ± 5.717 vs Control: 61.9 ± 2.607), ALT (DY: 229.8 ± 6.920 vs Control: 70.7 ± 3.109, DL: 123.75 ± 6.068 vs Control: 70.7 ± 3.109), and ALP (DY: 276.4 ± 18.154 vs Control: 320.6 ± 9.829, DL: 298.5 ± 12.336 vs Control: 320.6 ± 9.829) in IU/L. The analysis of histological alterations showed hepatic sinusoidal dilation with vein congestion and cell infiltration exclusively in DY rats along with other histological changes that are common to both test groups, thereby suggesting more pronounced alterations in DY rats. Further, LC-MS/MS based label-free quantitation of proteins from liver tissues revealed 74.75% up-regulated, 25.25% down-regulated in DY rats and 51.16% up-regulated, 48.84% down-regulated in DL experiments. The proteomics-identified proteins majorly belonged to metabolism, apoptosis, stress response and redox homeostasis, and detoxification and antioxidant defence that demonstrated the potential damage of rat liver, more pronounced in D*Y rats. Altogether the results are in favor that the administration of lactobacilli somewhat protected the rat hepatic cells against the diclofenac-induced toxicity.
双氯芬酸是一种肝毒性的非甾体抗炎药(NSAID),会影响肝脏组织学及其蛋白表达水平。在这里,我们研究了双氯芬酸与耶尔森氏菌 8081 血清型 O:8 生物型 1B(DY)或发酵乳杆菌 9338(DL)共同给药时对大鼠肝脏的影响。粪便样本的光谱分析显示双氯芬酸发生了生物转化。与彼此相比,DY 大鼠缺乏 1709 和 1198 cm 处的峰,而 DL 大鼠缺乏 1411 cm 处的峰。然而,与对照组相比,两组均缺乏 1379 和 1170 cm 处的峰。对血清肝毒性生物标志物的评估表明,AST(DY:185.65±8.575 比对照组:61.9±2.607,DL:247.5±5.717 比对照组:61.9±2.607)、ALT(DY:229.8±6.920 比对照组:70.7±3.109,DL:123.75±6.068 比对照组:70.7±3.109)和 ALP(DY:276.4±18.154 比对照组:320.6±9.829,DL:298.5±12.336 比对照组:320.6±9.829)的活性在 IU/L 中显著改变。组织学改变的分析显示,仅在 DY 大鼠中观察到肝窦扩张伴静脉充血和细胞浸润,以及两组共同存在的其他组织学改变,这表明 DY 大鼠的改变更为明显。此外,基于 LC-MS/MS 的肝组织蛋白无标记定量分析显示,DY 大鼠中有 74.75%的蛋白上调,25.25%的蛋白下调,DL 实验中有 51.16%的蛋白上调,48.84%的蛋白下调。蛋白质组学鉴定的蛋白质主要属于代谢、凋亡、应激反应和氧化还原稳态以及解毒和抗氧化防御,表明大鼠肝脏可能受到损害,在 D*Y 大鼠中更为明显。总的来说,这些结果表明,乳杆菌的给药在某种程度上保护了大鼠肝细胞免受双氯芬酸诱导的毒性。